Abdominal and pelvic CEST imaging: quantitative assessment of tissue function, tumor characteristic, tumor aggressiveness
Not Applicable
- Conditions
- ormal tissues and malignant tumors of liver, pancreas, kidney, uterus, prostate and GI
- Registration Number
- JPRN-UMIN000017546
- Lead Sponsor
- Kyushu University
- Brief Summary
There was a significant difference in APTSIs between GS of 6 and GS of 7, and GS of 7 and GS of 9, but no significant differences in APTSI between GS of 6 and GS of 8, GS of 6 and GS of 9, and GS of 7 and GS of 8. The increase The APTSI in GS of 7 was the highest. The APT-MRI has a possibility as a new biomarker of Pca aggressiveness.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Not provided
Exclusion Criteria
Contraindication of MRI
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of CEST effects between tumor and non-tumor region. Assessment of diagnostic capability of tumor aggressiveness and histological characteristics by radiological-histological correlation.
- Secondary Outcome Measures
Name Time Method